JP2002504330A
(en)
|
1998-02-19 |
2002-02-12 |
イースターン・バージニア・メディカル・スクール |
Recombinant active human zona pellucida protein 3 (hZP3)
|
US7037663B2
(en)
|
1998-02-19 |
2006-05-02 |
Eastern Virginia Medical School |
Human zona pellucida protein 3 and uses thereof
|
US20010053849A1
(en)
*
|
1999-06-16 |
2001-12-20 |
Mary Jeanne Kreek |
Plural biological sample arrays, and preparation and uses thereof
|
US7058517B1
(en)
|
1999-06-25 |
2006-06-06 |
Genaissance Pharmaceuticals, Inc. |
Methods for obtaining and using haplotype data
|
AU776600B2
(en)
*
|
1999-07-28 |
2004-09-16 |
Genentech Inc. |
Compositions and methods for the treatment of tumors
|
DE19955024C2
(en)
*
|
1999-11-16 |
2003-01-16 |
Adnagen Gmbh |
Diagnostic Kit
|
US20020077756A1
(en)
*
|
1999-11-29 |
2002-06-20 |
Scott Arouh |
Neural-network-based identification, and application, of genomic information practically relevant to diverse biological and sociological problems, including drug dosage estimation
|
US6931326B1
(en)
|
2000-06-26 |
2005-08-16 |
Genaissance Pharmaceuticals, Inc. |
Methods for obtaining and using haplotype data
|
DE60036935T2
(en)
|
2000-07-10 |
2008-08-21 |
Mor-Research Applications Ltd. |
Diagnostic procedure for ovarian and endometrial tumors based on the detection of the L1 adhesion molecule
|
DE10037769A1
(en)
*
|
2000-08-03 |
2002-02-21 |
Epigenomics Gmbh |
Diagnosis of diseases associated with CD24
|
US20030228320A1
(en)
*
|
2000-08-18 |
2003-12-11 |
Ashdown Martin Leonard |
Retroviral immunotherapy
|
DE10054972A1
(en)
*
|
2000-11-06 |
2002-06-06 |
Epigenomics Ag |
Diagnosis of diseases associated with humus
|
DE10054974A1
(en)
*
|
2000-11-06 |
2002-06-06 |
Epigenomics Ag |
Diagnosis of diseases associated with Cdk4
|
WO2002061131A2
(en)
*
|
2000-12-04 |
2002-08-08 |
Bristol-Myers Squibb Company |
Human single nucleotide polymorphisms
|
WO2002046460A2
(en)
*
|
2000-12-06 |
2002-06-13 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Method for detecting risk of atherosclerosis
|
DE10061338A1
(en)
*
|
2000-12-06 |
2002-06-20 |
Epigenomics Ag |
Diagnosis of diseases associated with angiogenesis
|
FR2817558A1
(en)
*
|
2000-12-06 |
2002-06-07 |
Inst Nat Sante Rech Med |
Determining risk of atherosclerosis and related diseases, by detecting specific alleles of the endothelin-converting enzyme-1 gene
|
WO2003008627A2
(en)
|
2001-07-20 |
2003-01-30 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Phenylthiocarbamide (ptc) taste receptor
|
EP1421104A4
(en)
|
2001-08-02 |
2005-08-24 |
Trinity Biomedical Technology |
Human zona pellucida proteins and methods of their use in diagnosing male infertility
|
US7172858B2
(en)
|
2001-11-28 |
2007-02-06 |
The General Hospital Corporation |
Blood-based assay for dysferlinopathies
|
JP2005523688A
(en)
*
|
2002-01-18 |
2005-08-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
Identification of polynucleotides and polypeptides for predicting the activity of protein tyrosine kinases and / or compounds that interact with protein tyrosine kinase pathways
|
AUPS054702A0
(en)
*
|
2002-02-14 |
2002-03-07 |
Immunaid Pty Ltd |
Cancer therapy
|
EP1340818A1
(en)
*
|
2002-02-27 |
2003-09-03 |
Epigenomics AG |
Method and nucleic acids for the analysis of a colon cell proliferative disorder
|
EP1918386B9
(en)
*
|
2002-03-13 |
2012-08-08 |
Genomic Health, Inc. |
Gene expression profiling in biopsied tumor tissues
|
US6764824B2
(en)
*
|
2002-03-21 |
2004-07-20 |
Council Of Scientific And Industrial Research |
Primers for screening schizophrenia and a method thereof
|
AU2002247937B2
(en)
*
|
2002-03-25 |
2007-05-24 |
Council Of Scientific And Industrial Research |
Novel primers for screening schizophrenia and a method thereof
|
DE10214788A1
(en)
*
|
2002-04-04 |
2003-10-23 |
Universitaetsklinikum Hamburg |
Method for detecting a mutation in a gene predisposed to hereditary colorectal tumors
|
GB0222042D0
(en)
*
|
2002-09-23 |
2002-10-30 |
Sciona Ltd |
Genostics
|
EP1570080A4
(en)
*
|
2002-11-15 |
2006-03-01 |
Genomic Health Inc |
Gene expression profiling of egfr positive cancer
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
EP1590487A2
(en)
*
|
2003-02-06 |
2005-11-02 |
Genomic Health, Inc. |
Gene expression markers for response to egfr inhibitor drugs
|
PT1597391E
(en)
*
|
2003-02-20 |
2008-12-19 |
Genomic Health Inc |
Use of intronic rna to measure gene expression
|
US20050064455A1
(en)
*
|
2003-05-28 |
2005-03-24 |
Baker Joffre B. |
Gene expression markers for predicting response to chemotherapy
|
WO2004111273A2
(en)
*
|
2003-05-30 |
2004-12-23 |
Genomic Health, Inc. |
Gene expression markers for response to egfr inhibitor drugs
|
CA2530738C
(en)
|
2003-06-24 |
2020-01-21 |
Genomic Health, Inc. |
Prediction of likelihood of cancer recurrence
|
WO2004113561A2
(en)
*
|
2003-06-25 |
2004-12-29 |
Queen's University At Kingston |
Methods for diagnosing, monitoring, staging and treating heart failure
|
ES2905579T3
(en)
*
|
2003-07-10 |
2022-04-11 |
Genomic Health Inc |
Expression profiling algorithm and test for prognosis of breast cancer relapse
|
US20050048543A1
(en)
*
|
2003-07-11 |
2005-03-03 |
Jeroen Aerssens |
CHRNA2 genetic markers associated with galantamine response
|
SE0302559D0
(en)
|
2003-09-25 |
2003-09-25 |
Astrazeneca Ab |
Method
|
WO2005040396A2
(en)
*
|
2003-10-16 |
2005-05-06 |
Genomic Health, Inc. |
qRT-PCR ASSAY SYSTEM FOR GENE EXPRESSION PROFILING
|
US20070202119A1
(en)
*
|
2003-10-24 |
2007-08-30 |
Ashdown Martin L |
Method Of Therapy
|
EP1561821B1
(en)
|
2003-12-11 |
2011-02-16 |
Epigenomics AG |
Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients
|
EP1694866A4
(en)
*
|
2003-12-12 |
2007-12-26 |
Bayer Pharmaceuticals Corp |
Gene expression profiles and methods of use
|
US7129049B2
(en)
*
|
2003-12-22 |
2006-10-31 |
Regents Of The University Of Minnesota |
Method of detecting equine glycogen storage disease IV
|
WO2005064019A2
(en)
|
2003-12-23 |
2005-07-14 |
Genomic Health, Inc. |
Universal amplification of fragmented rna
|
US7608458B2
(en)
*
|
2004-02-05 |
2009-10-27 |
Medtronic, Inc. |
Identifying patients at risk for life threatening arrhythmias
|
WO2005078452A1
(en)
*
|
2004-02-05 |
2005-08-25 |
Medtronic, Inc. |
Methods and apparatus for identifying patients at risk for life threatening arrhythmias
|
AU2011213758B2
(en)
*
|
2004-02-19 |
2012-11-15 |
Yale University |
Identification of cancer protein biomarkers using proteomic techniques
|
JP4912894B2
(en)
*
|
2004-02-19 |
2012-04-11 |
イェール ユニバーシティー |
Identification of oncoprotein biomarkers using proteomic technology
|
US7871769B2
(en)
*
|
2004-04-09 |
2011-01-18 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
US8335652B2
(en)
*
|
2004-06-23 |
2012-12-18 |
Yougene Corp. |
Self-improving identification method
|
US8027791B2
(en)
*
|
2004-06-23 |
2011-09-27 |
Medtronic, Inc. |
Self-improving classification system
|
US20050287574A1
(en)
*
|
2004-06-23 |
2005-12-29 |
Medtronic, Inc. |
Genetic diagnostic method for SCD risk stratification
|
EP1805510B1
(en)
*
|
2004-09-08 |
2012-02-22 |
Immunaid Pty Ltd |
Therapeutic strategy for treating autoimmune and degenerative diseases
|
AU2005297303B2
(en)
*
|
2004-10-19 |
2011-11-10 |
Lsip, Llc |
Novel diagnostic kit for malignant melanoma
|
ES2778851T3
(en)
*
|
2004-11-05 |
2020-08-12 |
Genomic Health Inc |
Prediction of response to chemotherapy using gene expression markers
|
DK1815014T3
(en)
|
2004-11-05 |
2012-06-18 |
Genomic Health Inc |
Molecular indicators of breast cancer prognosis and prediction of treatment response
|
EP1937837A2
(en)
*
|
2005-07-29 |
2008-07-02 |
Siemens Healthcare Diagnostics Inc. |
Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
|
US20100029504A1
(en)
*
|
2007-01-16 |
2010-02-04 |
Phigenix, Inc. |
Detecting pax2 for the diagnosis of breast cancer
|
EP2392647A1
(en)
|
2005-10-14 |
2011-12-07 |
MUSC Foundation For Research Development |
Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
|
US20070130694A1
(en)
*
|
2005-12-12 |
2007-06-14 |
Michaels Emily W |
Textile surface modification composition
|
EP1963523A2
(en)
*
|
2005-12-22 |
2008-09-03 |
Siemens Medical Solutions Diagnostics GmbH |
Method for the prediction of adverse drug responses
|
ES2491222T3
(en)
|
2006-01-11 |
2014-09-05 |
Genomic Health, Inc. |
Gene expression markers for colorectal cancer prognosis
|
GB0604370D0
(en)
*
|
2006-03-03 |
2006-04-12 |
Univ Dublin |
Markers for melanoma progression
|
EP1840227A1
(en)
*
|
2006-03-02 |
2007-10-03 |
University College Dublin |
Markers for melanoma
|
US7888019B2
(en)
|
2006-03-31 |
2011-02-15 |
Genomic Health, Inc. |
Genes involved estrogen metabolism
|
CN101970685B
(en)
|
2007-01-16 |
2013-08-07 |
Musc研究发展基金会 |
Kit for diagnosing prostate conditions
|
US20080228699A1
(en)
*
|
2007-03-16 |
2008-09-18 |
Expanse Networks, Inc. |
Creation of Attribute Combination Databases
|
US20090043752A1
(en)
*
|
2007-08-08 |
2009-02-12 |
Expanse Networks, Inc. |
Predicting Side Effect Attributes
|
US20100326218A1
(en)
*
|
2007-09-27 |
2010-12-30 |
Michael Boeckh |
Identifying a subject with an increased risk of invasive mold infection
|
US20110143956A1
(en)
*
|
2007-11-14 |
2011-06-16 |
Medtronic, Inc. |
Diagnostic Kits and Methods for SCD or SCA Therapy Selection
|
WO2009064973A2
(en)
*
|
2007-11-14 |
2009-05-22 |
Medtronic Inc. |
Diagnostic kits and methods for scd or sca therapy selection
|
US8200509B2
(en)
*
|
2008-09-10 |
2012-06-12 |
Expanse Networks, Inc. |
Masked data record access
|
US7917438B2
(en)
|
2008-09-10 |
2011-03-29 |
Expanse Networks, Inc. |
System for secure mobile healthcare selection
|
US20100076988A1
(en)
*
|
2008-09-10 |
2010-03-25 |
Expanse Networks, Inc. |
Masked Data Service Profiling
|
US20100070292A1
(en)
*
|
2008-09-10 |
2010-03-18 |
Expanse Networks, Inc. |
Masked Data Transaction Database
|
US20100063835A1
(en)
*
|
2008-09-10 |
2010-03-11 |
Expanse Networks, Inc. |
Method for Secure Mobile Healthcare Selection
|
US20100076950A1
(en)
*
|
2008-09-10 |
2010-03-25 |
Expanse Networks, Inc. |
Masked Data Service Selection
|
US20100063865A1
(en)
*
|
2008-09-10 |
2010-03-11 |
Expanse Networks, Inc. |
Masked Data Provider Profiling
|
US20100063830A1
(en)
*
|
2008-09-10 |
2010-03-11 |
Expanse Networks, Inc. |
Masked Data Provider Selection
|
US8108406B2
(en)
|
2008-12-30 |
2012-01-31 |
Expanse Networks, Inc. |
Pangenetic web user behavior prediction system
|
US8386519B2
(en)
|
2008-12-30 |
2013-02-26 |
Expanse Networks, Inc. |
Pangenetic web item recommendation system
|
EP3276526A1
(en)
|
2008-12-31 |
2018-01-31 |
23Andme, Inc. |
Finding relatives in a database
|
SG10201401722XA
(en)
|
2009-05-01 |
2014-08-28 |
Genomic Health Inc |
Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer andresponse to chemotherapy
|
WO2010132546A2
(en)
*
|
2009-05-12 |
2010-11-18 |
Medtronic, Inc. |
Sca risk stratification by predicting patient response to anti-arrhythmics
|
PL2435825T3
(en)
|
2009-05-27 |
2015-12-31 |
Biotempus Ltd |
Methods of treating diseases
|
US20110237537A1
(en)
*
|
2009-05-29 |
2011-09-29 |
Lombard Jay L |
Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis
|
EP2435586A4
(en)
*
|
2009-05-29 |
2012-12-26 |
Genomind Llc |
Methods for assessment and treatment of depression via utilization of single nucleotide polymorphisms analysis
|
US8355927B2
(en)
|
2010-11-05 |
2013-01-15 |
Genomind, Llc |
Neuropsychiatric test reports
|
CA2804626C
(en)
|
2010-07-27 |
2020-07-28 |
Genomic Health, Inc. |
Method for using expression of glutathione s-transferase mu 2 (gstm2) to determine prognosis of prostate cancer
|
MX366164B
(en)
|
2012-01-31 |
2019-07-01 |
Genomic Health Inc |
Gene expression profile algorithm and test for determining prognosis of prostate cancer.
|
KR101765999B1
(en)
*
|
2015-01-21 |
2017-08-08 |
서울대학교산학협력단 |
Device and Method for evaluating performace of cancer biomarker
|
WO2016169807A1
(en)
*
|
2015-04-22 |
2016-10-27 |
Nestec S.A. |
Biomarkers for predicting degree of weight loss in female subjects
|
WO2016169806A1
(en)
*
|
2015-04-22 |
2016-10-27 |
Nestec S.A. |
Biomarkers for predicting degree of weight loss in male subjects
|
WO2019041045A1
(en)
|
2017-09-01 |
2019-03-07 |
The Hospital For Sick Children |
Profiling and treatment of hypermutant cancer
|
US11905561B2
(en)
|
2018-10-16 |
2024-02-20 |
King Faisal Specialist Hospital & Research Centre |
Method for diagnosing or treating pulmonary fibrosis using S100A13 protein
|
CN110687284B
(en)
*
|
2019-08-26 |
2023-05-23 |
中国医学科学院肿瘤医院 |
Application of reagent for detecting SIX2 autoantibody in serum
|
US11834756B2
(en)
|
2019-09-13 |
2023-12-05 |
Google Llc |
Methods and compositions for protein and peptide sequencing
|
US11926820B2
(en)
*
|
2019-09-13 |
2024-03-12 |
Google Llc |
Methods and compositions for protein and peptide sequencing
|
US11031119B2
(en)
*
|
2019-11-13 |
2021-06-08 |
Cube Click, Inc. |
Dental images processed with deep learning for national security
|
EP4196611A1
(en)
|
2020-08-15 |
2023-06-21 |
Regeneron Pharmaceuticals, Inc. |
Treatment of obesity in subjects having variant nucleic acid molecules encoding calcitonin receptor (calcr)
|
CN113533748B
(en)
*
|
2021-07-15 |
2024-02-13 |
无锡市儿童医院 |
Combined kit for predicting asthma attacks of children and application of combined kit
|
WO2023225221A1
(en)
*
|
2022-05-18 |
2023-11-23 |
The Johns Hopkins University |
Machine learning system for predicting gene cleavage sites background
|